Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2016
TORONTO, ONTARIO--(Marketwired - Oct 20, 2016) - Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on commercializing treatments for rare diseases such as Cystinuria, Wilson's …